Editor’s pick: 8 data-driven healthcare trends to watch

AI, blockchain and mHealth apps specific to Big Data are among eight emerging technologies healthcare watchers would do well to keep an eye on, according to a consumer-friendly roundup published Aug. 7 in the Santa Clarita Valley Signal.

Not a lot new is here, but the newspaper has done a solid service presenting casual technology watchers with the basics on each trending topic it names.

“Given that the AI is set to grow exponentially, it could mean that, very soon, we can see some major breakthroughs in healthcare such as doctors conducting complex surgeries using AI, patients performing self-examination and much more,” according to the piece.

Also: “Looking at its usage and popularity, blockchain technology shall bring massive breakthroughs and will be one of the most sought-after trends for 2019 and beyond.”

Despite missteps with editorial details like syntax and capitalization, the piece is worth a read—or at least a forward to a friend or family member.

Click to access:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.